abhadya chura and mukta bhasma in the management of Ashthi Kshaya.

clinical evaluation of abhadya chura and mukta bhasma in the management of Osteopenia/osteoporosis(Ashthi Kshaya)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008614

Enrollment

100

Registered

2017-05-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M199- Osteoarthritis, unspecified site Health Condition 2: null- patients of either sex inbetween 45 to 65 years. BMDT score -1

Interventions

Intervention1: ABHADYA CHURNA (AFI,PART -III)-5gm twice daily MUKTASUKTI BASMA (AFI,PART-I, VOL-I, 238-239)-250mg twice daily: Both mentioned in Ayurveda pharmacopoeia and have used by contemporary ay

Eligibility

Inclusion criteria

Inclusion criteria: BMD T score less than -1

Exclusion criteria

Exclusion criteria: fragidity of bone, endocrine dis0rders,patients having poorly controlled hypertension, serum calcium less than 2.6 and more than 10.5 mg/dl

Design outcomes

Primary

Measure	Time frame
change in quality of life index,Timepoint: 12 weeks	—

Secondary

Measure	Time frame
change BMD Tscore, Bone specific alkaline phospatase changeTimepoint: 12 weeks	—

Countries

India

Contacts

Public ContactDr Ashok Kumar Panda

CCRAS, New Delhi

akpanda_06@yahoo.co.in9434631670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026